Table I.
No. Enriched Genes / No. Total Genes | Adjusted P value | ||
---|---|---|---|
Biologic process | Immune system process | 136/613 | 6.43E-16 |
Immune response | 103/410 | 1.31E-15 | |
Defense response | 83/353 | 1.52E-10 | |
Death | 123/690 | 1.71E-07 | |
Cell death | 122/687 | 2.10E-07 | |
Response to stimulus | 244/1678 | 2.83E-07 | |
Programmed cell death | 114/650 | 1.31E-06 | |
Apoptosis | 113/646 | 1.59E-06 | |
Signal transduction | 293/2154 | 3.00E-06 | |
Cell communication | 312/2340 | 6.13E-06 | |
Pathway | Natural killer cell mediated cytotoxicity | 35/104 | 7.19E-10 |
Graft-versus-host disease | 21/37 | 8.47E-10 | |
Cytokine-cytokine receptor interaction | 40/146 | 1.51E-09 | |
Antigen processing and presentation | 24/68 | 3.54E-06 | |
Allograft rejection | 14/30 | 3.62E-05 | |
Asthma | 10/20 | 0.00070 | |
Type I diabetes mellitus | 13/33 | 0.00172 | |
Autoimmune thyroid disease | 12/35 | 0.00604 |